To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Pixantrone (rINN, codenamed BBR2778) is an immunosuppressant drug, an analogue of mitoxantrone with less toxic effects on cardiac tissue. It is being studied as an antineoplastic for different kinds of cancer, including solid tumors and hematological malignancies such as non-Hodgkin lymphomas.
Additional recommended knowledge
It is also as potent as mitoxantrone in animal models of multiple sclerosis; however, results of human trials had not been published in 2007.
As of 2007, several phase III clinical trials of pixantrone are underway.
Categories: Chemotherapeutic agents | Immunosuppressive agents | Quinones
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Pixantrone". A list of authors is available in Wikipedia.|